Looking for Growth? These Companies' Revenue May Skyrocket
As we move closer to a bull market, you may be looking to add a few promising growth stocks to your portfolio. After all, these stocks often thrive during times of market optimism and expansion. So, today, it's a great idea to look for companies that not only have great long-term prospects but also have a potential growth catalyst (or catalysts) around the corner.
You might find candidates in any industry, but today I'll look at two biotech companies and one consumer goods company that truly stand out. Their revenue could skyrocket thanks to new projects unfolding right now, and considering their growth potential, they look very reasonably priced. Let's take a look at these potential winners...
(NASDAQ: MRNA) today is known for its blockbuster coronavirus vaccine. But a few years from now, this biotech may become a multi-product company generating as much as $30 billion in annual revenue. The company said this week it plans on launching as many as 15 products in the next five years and bringing possibly 50 new candidates into clinical studies.
Source Fool.com
Moderna Inc. Stock
We see a rather positive sentiment for Moderna Inc. with 17 Buy predictions and 2 Sell predictions.
With a target price of 129 € there is a slightly positive potential of 13.36% for Moderna Inc. compared to the current price of 113.8 €.
